Clinical Role - Specialty Pharmacy
Pharmacy Times® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.
Pharmacists can play an integral role in educating patients with breast cancer to improve health outcomes.
Pharmacy-Integrated Telehealth Solutions Support Patients with Orphan and Ultraorphan Disorders During and After COVID-19 Pandemic
A recent poll showed that more than 1 in 8 Americans engaged in a video consult with a health care professional in recent months.
Although ICIs have demonstrated excellent efficacy, they also have been associated with unique irAEs.
Study: AI May Help Predict Response to Immune Checkpoint Blockade in Patients With Metastatic Melanoma
To analyze digital images of metastatic tumors of melanoma, the researchers used computer algorithms, or deep convolutional neural networks (DCCN), to identify patterns associated with treatment response.
By supplying proper PPE and infrastructure, health systems can keep workers safe and provide excellent patient care.
FDA grants fast track designation to the BTK inhibitor rilzabrutinib for the treatment of patients with immune thrombocytopenia.
Residency programs in specialty pharmacy are relatively new, emerging in response to dramatic growth in the specialty sector.
Researchers hope clinical trials will begin soon to evaluate oral LMTK3 inhibitors across cancer types.
A review of the biologics license application for lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphoma following at least 2 previous therapies has been delayed.
PD-L1 IHC 22C3 pharmDx will aid in the identification of patients with triple-negative breast cancer eligible for treatment with pembrolizumab.
Although a single IVIG dose of 25 g was effective in most cases, for some strains repeated doses were necessary to achieve a significant reduction in superantigenic responses.
In the years following the passage of the Affordable Care Act, early-stage cancer diagnosis increased while late-stage fell.